The original THYROSIM (developed for mixed male–female normal weight patients) was previously used to simulate a wide range of RTF values in typical hypothyroid patients with reduced thyroid hormone secretion rates and their simulated responses to practical combinations of optimized LT3 and LT4 doses (26). This evidence concerns the gene TG and hypothyroidism.